Literature DB >> 9448376

A quantitative review of cognitive deficits in depression and Alzheimer-type dementia.

H Christensen1, K Griffiths, A Mackinnon, P Jacomb.   

Abstract

Meta-analysis was used to examine the performance of depressed and Alzheimer-type dementia (DAT) patients on standard and experimental clinical tests of cognitive function. Deficits were found for depression on almost every psychological test. Relative to nondepressed controls, the average deficit was 0.63 of a standard deviation, but the magnitude of the effect varied with the type of test. DAT patients performed worse than depressed patients, with an average effect size of 1.21 standard deviations, but the size of the effect depended on the clinical test. Effect sizes for the comparison between depressives and controls were significantly affected by age, treatment setting, ECT use, severity of depression, and the source of diagnostic criteria, but not by the type of depression. Effect sizes in the comparison of depressives to DAT patients were influenced by age, the severity of depression, and ECT. Depressives performed proportionately worse than controls on tasks with pleasant or neutral, compared with unpleasant content, on speeded compared with nonspeeded tasks, and on vigilance tasks. However, there were no differences in the magnitude of effect size for tests using recall compared with recognition, using categorical compared with noncategorical word lists, on story compared with word comprehension, and using verbal compared with visual material. Relative to DAT patients, depressives performed no better on recall compared to recognition tasks, or verbal compared to visual material. The findings of the review are not consistent with the hypothesis that depression is associated with deficits in effortful processing. A model of psychological deficit in depression as a deficit in speed or attention has more promise.

Entities:  

Mesh:

Year:  1997        PMID: 9448376

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  45 in total

1.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

Review 2.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

3.  Is episodic memory performance more vulnerable to depressive affect in older adulthood?

Authors:  Jarrett Evans; Neil Charness; Katinka Dijkstra; Joanna M Fitzgibbons; Jong-Sung Yoon
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2018-01-09

Review 4.  Distinguishing Alzheimer's disease from other major forms of dementia.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 5.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

6.  Frontal brain asymmetry in depression with comorbid anxiety: a neuropsychological investigation.

Authors:  Brady D Nelson; Casey Sarapas; E Jenna Robison-Andrew; Sarah E Altman; Miranda L Campbell; Stewart A Shankman
Journal:  J Abnorm Psychol       Date:  2012-03-19

7.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

8.  Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study.

Authors:  Y S Shim; C-U Pae; K J Cho; S W Kim; J C Kim; J S Koh
Journal:  Int J Impot Res       Date:  2013-11-28       Impact factor: 2.896

Review 9.  The association between cognitive function and subsequent depression: a systematic review and meta-analysis.

Authors:  M A Scult; A R Paulli; E S Mazure; T E Moffitt; A R Hariri; T J Strauman
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

10.  Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression.

Authors:  Vishal Bali; Michael L Johnson; Hua Chen; Marc L Fleming; Holly M Holmes; Rajender R Aparasu
Journal:  Ann Pharmacother       Date:  2015-11-25       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.